Amylyx Pharmaceuticals (AMLX) Net Margin Growth (1y) (2022 - 2024)
Amylyx Pharmaceuticals (AMLX) Net Margin Growth (1y) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.35 Bn | 4.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -401,349.00 |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -712,902.00 |
| Mar 31, 2024 | -13,622.00 |
| Dec 31, 2023 | 20,266.00 |
| Sep 30, 2023 | 1.56 Mn |
| Sep 30, 2022 | -746,145.00 |